Search research articles
Contact Us
Filters
Showing results (1211-1220 of 1,312) with videos related to
Page
of 132
Sort By:
Molecular Psychiatry
|
February 4, 2009
Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15
Y-Z Liu, Y-F Pei, Y-F Guo, et al.
Environmental Health Perspectives
|
May 15, 2009
Impacts of climate change on indirect human exposure to pathogens and chemicals from agriculture
Alistair B A Boxall, Anthony Hardy, Sabine Beulke, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
William R Lumry, Timothy Craig, Bruce Zuraw, et al.
Journal of Dental Research
|
June 16, 2026
Multiancestral GWAS of Dental Malocclusion Identifies Multiple Risk Loci
A Alade, J M Maurer, J Anderton, et al.
Microbiome
|
May 27, 2021
Characterization of the public transit air microbiome and resistome reveals geographical specificity
M H Y Leung, X Tong, K O Bøifot, et al.
Science (New York, N.Y.)
|
December 15, 1989
Voyager radio science observations of neptune and triton
G L Tyler, D N Sweetnam, J D Anderson, et al.
Annals of Surgery
|
July 18, 2020
Proving the Effectiveness of the Fundamentals of Robotic Surgery (FRS) Skills Curriculum: A Single-blinded, Multispecialty, Multi-institutional Randomized Control Trial
Richard M Satava, Dimitrios Stefanidis, Jeffrey S Levy, et al.
Journal of Hematology & Oncology
|
November 29, 2013
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, et al.
FEMS Microbiology Reviews
|
June 1, 1997
Applications of S-layers
U B Sleytr, H Bayley, M Sára, et al.
Haematologica
|
January 25, 2015
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Page
of 132
Search research articles
Search
Showing results (1211-1220 of 1,312) with videos related to
Sort By:
Page
of 132
Molecular Psychiatry
|
February 4, 2009
Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15
Y-Z Liu, Y-F Pei, Y-F Guo, et al.
Environmental Health Perspectives
|
May 15, 2009
Impacts of climate change on indirect human exposure to pathogens and chemicals from agriculture
Alistair B A Boxall, Anthony Hardy, Sabine Beulke, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
William R Lumry, Timothy Craig, Bruce Zuraw, et al.
Journal of Dental Research
|
June 16, 2026
Multiancestral GWAS of Dental Malocclusion Identifies Multiple Risk Loci
A Alade, J M Maurer, J Anderton, et al.
Microbiome
|
May 27, 2021
Characterization of the public transit air microbiome and resistome reveals geographical specificity
M H Y Leung, X Tong, K O Bøifot, et al.
Science (New York, N.Y.)
|
December 15, 1989
Voyager radio science observations of neptune and triton
G L Tyler, D N Sweetnam, J D Anderson, et al.
Annals of Surgery
|
July 18, 2020
Proving the Effectiveness of the Fundamentals of Robotic Surgery (FRS) Skills Curriculum: A Single-blinded, Multispecialty, Multi-institutional Randomized Control Trial
Richard M Satava, Dimitrios Stefanidis, Jeffrey S Levy, et al.
Journal of Hematology & Oncology
|
November 29, 2013
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, et al.
FEMS Microbiology Reviews
|
June 1, 1997
Applications of S-layers
U B Sleytr, H Bayley, M Sára, et al.
Haematologica
|
January 25, 2015
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Page
of 132